Rare diseases
Investigational molecules
Locations
Study of UCART22 for Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
FranceStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
FranceStudy Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma
FranceStudy of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery
FranceStudy of Radiotherapy with Cetuximab and Xevinapant for Patients with Advanced Head and Neck Cancer Unfit for High-Dose Cisplatin
FranceStudy on Rifaximin for Delaying Hepatic Encephalopathy in Cirrhosis Patients
FranceStudy to Determine Safe Doses of Selexipag for Children with Pulmonary Arterial Hypertension
FranceStudy on Ampreloxetine and Midodrine Hydrochloride for Treating Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy
FranceStudy on the Safety and Effects of BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia
FranceStudy on the Long-Term Safety and Effectiveness of Amlitelimab for Adults with Moderate to Severe Atopic Dermatitis
FranceStudy Comparing Sacituzumab Govitecan with Other Treatments for Patients with HR+/HER2- Metastatic Breast Cancer After Endocrine Therapy
FranceStudy on Long-Term Safety of Ligelizumab for Patients with Food Allergies
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
